Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Foeldvari

Showing results (41-50 of 174) with videos related to

Pageof 18
Sort By:
Pediatric Rheumatology Online Journal|June 26, 2026
Identifying outcome measures for clinical trials in juvenile idiopathic arthritis associated uveitis for the MIWGUC proposal: a scoping review to create domains from existing outcome measuresIlaria Maccora, Giulia Inguscio, Stefano Romano, et al.
Journal of Scleroderma and Related Disorders|November 15, 2024
What are Juvenile-onset systemic sclerosis providers thoughts, experiences, and reasons for autologous stem cell transplant? Result of a multinational surveyIvan Foeldvari, Samantha Branton, Suzanne C Li, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Update on malignancies in children with juvenile idiopathic arthritis in the German BIKER RegistryGerd Horneff, Ariane Klein, Prasad T Oommen, et al.
Rheumatology (Oxford, England)|March 27, 2012
Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBOKirsten Minden, Martina Niewerth, Angela Zink, et al.
The Journal of Rheumatology|December 7, 2005
Scleroderma--developing measures of responseDaniel E Furst, Dinesh Khanna, Marco Mattucci-Cerinic, et al.
Pediatric Rheumatology Online Journal|November 9, 2017
Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritisGerd Horneff, Ariane Klein, Gerd Ganser, et al.
Rheumatology International|February 16, 2021
Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registryFranz Thiele, Ariane Klein, Daniel Windschall, et al.
Children (Basel, Switzerland)|November 27, 2021
Does Juvenile Idiopathic Arthritis Affect the Course of Legg-Calvé-Perthes Disease? A Case-Control Study with a Mean Follow-Up of 8 YearsJulien Roß, Ivan Foeldvari, Kara L Krajewski, et al.
Annals of the Rheumatic Diseases|April 18, 2020
Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritisAriane Klein, Kirsten Minden, Anton Hospach, et al.
Arthritis Research & Therapy|April 17, 2021
Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritisJens Klotsche, Ariane Klein, Martina Niewerth, et al.
Pageof 18

Showing results (41-50 of 174) with videos related to

Sort By:
Pageof 18
Pediatric Rheumatology Online Journal|June 26, 2026
Identifying outcome measures for clinical trials in juvenile idiopathic arthritis associated uveitis for the MIWGUC proposal: a scoping review to create domains from existing outcome measuresIlaria Maccora, Giulia Inguscio, Stefano Romano, et al.
Journal of Scleroderma and Related Disorders|November 15, 2024
What are Juvenile-onset systemic sclerosis providers thoughts, experiences, and reasons for autologous stem cell transplant? Result of a multinational surveyIvan Foeldvari, Samantha Branton, Suzanne C Li, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Update on malignancies in children with juvenile idiopathic arthritis in the German BIKER RegistryGerd Horneff, Ariane Klein, Prasad T Oommen, et al.
Rheumatology (Oxford, England)|March 27, 2012
Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBOKirsten Minden, Martina Niewerth, Angela Zink, et al.
The Journal of Rheumatology|December 7, 2005
Scleroderma--developing measures of responseDaniel E Furst, Dinesh Khanna, Marco Mattucci-Cerinic, et al.
Pediatric Rheumatology Online Journal|November 9, 2017
Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritisGerd Horneff, Ariane Klein, Gerd Ganser, et al.
Rheumatology International|February 16, 2021
Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registryFranz Thiele, Ariane Klein, Daniel Windschall, et al.
Children (Basel, Switzerland)|November 27, 2021
Does Juvenile Idiopathic Arthritis Affect the Course of Legg-Calvé-Perthes Disease? A Case-Control Study with a Mean Follow-Up of 8 YearsJulien Roß, Ivan Foeldvari, Kara L Krajewski, et al.
Annals of the Rheumatic Diseases|April 18, 2020
Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritisAriane Klein, Kirsten Minden, Anton Hospach, et al.
Arthritis Research & Therapy|April 17, 2021
Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritisJens Klotsche, Ariane Klein, Martina Niewerth, et al.
Pageof 18